Scott Dove, Ph.D., serves as vice president and global head of early development for PPD. In this role, he provides strategic direction and oversight of PPD’s early development clinical research units, external site network, CRO services and business development team.
Dr. Dove rejoined PPD in 2017 in his current role. Previously, he had been with PPD for 10 years in a variety of product development, compound partnering and medical writing leadership positions. He also spent five years with Furiex Pharmaceuticals, an independent company spun out from PPD’s compound partnering division, prior to its acquisition by Actavis (now Allergan). Immediately before returning to PPD, he served as executive director of clinical development in gastroenterology for Allergan. He has nearly 20 years of drug development experience.
Dr. Dove has earned a doctorate in pharmacology and a Bachelor of Science in biochemistry, both from Texas A&M University.